Hilary Eaton

Hilary Eaton is an accomplished professional with a diverse educational background and extensive experience in the biopharmaceutical industry.

She holds a Ph.D. in Molecular Cancer Biology from Duke University, a B.A. in Spanish, and a B.S. in Zoology from Michigan State University.

Currently, Hilary serves as the Senior Director of Business Development and Head of PR at Vor Biopharma, where she plays a crucial role in strategic decision-making and public relations.

Prior to her current role, she held various positions at Vor Biopharma and Editas Medicine, focusing on business development and licensing.

Before entering the industry, Hilary gained experience in technology transfer and consulting through roles at Belfer Office for Dana-Farber Innovations and The Boston Consulting Group.

Her academic journey includes a teaching assistant position at Harvard University Extension School, postdoctoral fellowships at Harvard Medical School and Duke University, as well as editorial work for the American Journal Experts.

With a strong foundation in cancer biology, coupled with business acumen and a background in teaching and research, Hilary Eaton is a well-rounded professional excelling in both the scientific and business aspects of the biopharmaceutical field.